APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 139 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,510,331 | +10.7% | 92,280 | +165.2% | 0.01% | 0.0% |
| Q2 2023 | $3,169,916 | +50.5% | 34,796 | +9.0% | 0.01% | +80.0% |
| Q1 2023 | $2,105,707 | -34.8% | 31,924 | -48.9% | 0.01% | -50.0% |
| Q4 2022 | $3,231,875 | +15.4% | 62,500 | +52.4% | 0.01% | +11.1% |
| Q3 2022 | $2,801,000 | +4.6% | 41,000 | -30.7% | 0.01% | 0.0% |
| Q2 2022 | $2,677,000 | +71.1% | 59,200 | +92.1% | 0.01% | +80.0% |
| Q1 2022 | $1,565,000 | -31.5% | 30,818 | -55.5% | 0.01% | -37.5% |
| Q3 2021 | $2,284,000 | +55.8% | 69,300 | +198.8% | 0.01% | +33.3% |
| Q2 2021 | $1,466,000 | +53.7% | 23,196 | -20.6% | 0.01% | 0.0% |
| Q2 2020 | $954,000 | +56.7% | 29,225 | +28.7% | 0.01% | +50.0% |
| Q1 2020 | $609,000 | +6.3% | 22,708 | +21.4% | 0.00% | 0.0% |
| Q4 2019 | $573,000 | – | 18,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
| Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
| SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
| Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
| HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
| CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
| Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
| Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
| Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
| Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |